# Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy

> **NCT06459193** · PHASE1,PHASE2 · COMPLETED · sponsor: **Minia University** · enrollment: 60 (actual)

## Conditions studied

- Peripheral Neuropathy Due to Chemotherapy

## Interventions

- **DRUG:** Trimetazidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06459193
- **Lead sponsor:** Minia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-23
- **Primary completion:** 2025-01-28
- **Final completion:** 2025-03-27
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06459193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06459193, "Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06459193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*